22nd Century Group has sold GVB Biopharma to Specialty Acquisition Corporation
Client: 22nd Century Group
Client Location: United States
Target: GVB Biopharma
Target Location: United States
Acquirer: Speciality Acquisition Corporation
Acquirer Location: United States
Target Description: GVB grows, manufactures and processes hemp cannabinoid products.
Meet our Senior Team
View More Transactions in Valuations & Opinions
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.